ACE2 and COVID-19: Significantly, ACE2 is localized on endothelial cells (Gallagher et al., 2008), and SARS-CoV-2 has recently been shown to cause endothelial cell infections across vascular beds in COVID-19 patients (Varga et al., 2020).